ACOT9
Acot9: A Novel Target for Immunotherapy
Description
Acot9, also known as Acyl-CoA thioesterase 9, is a recently discovered protein that plays a crucial role in lipid metabolism. It is a membrane-bound enzyme that is highly expressed in immune cells, such as T cells and macrophages. Acot9 is involved in the breakdown of fatty acids into acetyl-CoA, which is an essential energy source for cells.
Associated Diseases
Recent research has implicated Acot9 in the development and progression of several diseases, including:
- Cancer: Acot9 has been found to be overexpressed in various types of cancer, including breast, lung, and colon cancer. High Acot9 expression is associated with increased tumor growth, invasion, and metastasis.
- Autoimmune disorders: Acot9 deficiency has been linked to the development of autoimmune diseases, such as rheumatoid arthritis and lupus.
- Metabolic diseases: Acot9 is involved in lipid metabolism, and its dysregulation can lead to metabolic diseases such as obesity and type 2 diabetes.
Did you Know ?
A study published in the journal Nature Medicine found that mice lacking Acot9 exhibited reduced tumor growth and metastasis in a mouse model of breast cancer. This finding highlights the potential of Acot9 as a therapeutic target for cancer treatment.
